Epicrispr Biotechnologies
Develops programmable epigenetic medicines to treat genetic diseases like FSHD
$90MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops programmable epigenetic medicines to treat genetic diseases like FSHD
Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers
Pitching Fidelity Management & Research Company? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room